Cargando…
Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero
BACKGROUND: Children exposed to maternal smoking during pregnancy exhibit increased risk for many adverse health effects. Maternal smoking influences methylation in newborns at specific CpG sites (CpGs). Here, we extend evaluation of individual CpGs to gene-level and pathway-level analyses among 106...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124223/ https://www.ncbi.nlm.nih.gov/pubmed/27887572 http://dx.doi.org/10.1186/s12864-016-3310-1 |
_version_ | 1782469821827383296 |
---|---|
author | Rotroff, Daniel M. Joubert, Bonnie R. Marvel, Skylar W. Håberg, Siri E. Wu, Michael C. Nilsen, Roy M. Ueland, Per M. Nystad, Wenche London, Stephanie J. Motsinger-Reif, Alison |
author_facet | Rotroff, Daniel M. Joubert, Bonnie R. Marvel, Skylar W. Håberg, Siri E. Wu, Michael C. Nilsen, Roy M. Ueland, Per M. Nystad, Wenche London, Stephanie J. Motsinger-Reif, Alison |
author_sort | Rotroff, Daniel M. |
collection | PubMed |
description | BACKGROUND: Children exposed to maternal smoking during pregnancy exhibit increased risk for many adverse health effects. Maternal smoking influences methylation in newborns at specific CpG sites (CpGs). Here, we extend evaluation of individual CpGs to gene-level and pathway-level analyses among 1062 participants in the Norwegian Mother and Child Cohort Study (MoBa) using the Illumina 450 K platform to measure methylation in newborn DNA and maternal smoking in pregnancy, assessed using the biomarker, plasma cotinine. We used novel implementations of bioinformatics tools to collapse epigenome-wide methylation data into gene- and pathway-level effects to test whether exposure to maternal smoking in utero differentially methylated CpGs in genes enriched in biologic pathways. Unlike most pathway analysis applications, our approach allows replication in an independent cohort. RESULTS: Data on 485,577 CpGs, mapping to a total of 20,199 genes, were used to create gene scores that were tested for association with maternal plasma cotinine levels using Sequence Kernel Association Test (SKAT), and 15 genes were found to be associated (q < 0.25). Six of these 15 genes (GFI1, MYO1G, CYP1A1, RUNX1, LCTL, and AHRR) contained individual CpGs that were differentially methylated with regards to cotinine levels (p < 1.06 × 10(−7)). Nine of the 15 genes (FCRLA, MIR641, SLC25A24, TRAK1, C1orf180, ITLN2, GLIS1, LRFN1, and MIR451) were associated with cotinine at the gene-level (q < 0.25) but had no genome-wide significant individual CpGs (p > 1.06 × 10(−7)). Pathway analyses using gene scores resulted in 51 significantly associated pathways, which we tested for replication in an independent cohort (q < 0.05). Of those 32 replicated in an independent cohort, which clustered into six groups. The largest cluster consisted of pathways related to cancer, cell cycle, ERα receptor signaling, and angiogenesis. The second cluster, organized into five smaller pathway groups, related to immune system function, such as T-cell regulation and other white blood cell related pathways. CONCLUSIONS: Here we use novel implementations of bioinformatics tools to determine biological pathways impacted through epigenetic changes in utero by maternal smoking in 1062 participants in the MoBa, and successfully replicate these findings in an independent cohort. The results provide new insight into biological mechanisms that may contribute to adverse health effects from exposure to tobacco smoke in utero. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-3310-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5124223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51242232016-12-08 Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero Rotroff, Daniel M. Joubert, Bonnie R. Marvel, Skylar W. Håberg, Siri E. Wu, Michael C. Nilsen, Roy M. Ueland, Per M. Nystad, Wenche London, Stephanie J. Motsinger-Reif, Alison BMC Genomics Research Article BACKGROUND: Children exposed to maternal smoking during pregnancy exhibit increased risk for many adverse health effects. Maternal smoking influences methylation in newborns at specific CpG sites (CpGs). Here, we extend evaluation of individual CpGs to gene-level and pathway-level analyses among 1062 participants in the Norwegian Mother and Child Cohort Study (MoBa) using the Illumina 450 K platform to measure methylation in newborn DNA and maternal smoking in pregnancy, assessed using the biomarker, plasma cotinine. We used novel implementations of bioinformatics tools to collapse epigenome-wide methylation data into gene- and pathway-level effects to test whether exposure to maternal smoking in utero differentially methylated CpGs in genes enriched in biologic pathways. Unlike most pathway analysis applications, our approach allows replication in an independent cohort. RESULTS: Data on 485,577 CpGs, mapping to a total of 20,199 genes, were used to create gene scores that were tested for association with maternal plasma cotinine levels using Sequence Kernel Association Test (SKAT), and 15 genes were found to be associated (q < 0.25). Six of these 15 genes (GFI1, MYO1G, CYP1A1, RUNX1, LCTL, and AHRR) contained individual CpGs that were differentially methylated with regards to cotinine levels (p < 1.06 × 10(−7)). Nine of the 15 genes (FCRLA, MIR641, SLC25A24, TRAK1, C1orf180, ITLN2, GLIS1, LRFN1, and MIR451) were associated with cotinine at the gene-level (q < 0.25) but had no genome-wide significant individual CpGs (p > 1.06 × 10(−7)). Pathway analyses using gene scores resulted in 51 significantly associated pathways, which we tested for replication in an independent cohort (q < 0.05). Of those 32 replicated in an independent cohort, which clustered into six groups. The largest cluster consisted of pathways related to cancer, cell cycle, ERα receptor signaling, and angiogenesis. The second cluster, organized into five smaller pathway groups, related to immune system function, such as T-cell regulation and other white blood cell related pathways. CONCLUSIONS: Here we use novel implementations of bioinformatics tools to determine biological pathways impacted through epigenetic changes in utero by maternal smoking in 1062 participants in the MoBa, and successfully replicate these findings in an independent cohort. The results provide new insight into biological mechanisms that may contribute to adverse health effects from exposure to tobacco smoke in utero. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-3310-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-25 /pmc/articles/PMC5124223/ /pubmed/27887572 http://dx.doi.org/10.1186/s12864-016-3310-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Rotroff, Daniel M. Joubert, Bonnie R. Marvel, Skylar W. Håberg, Siri E. Wu, Michael C. Nilsen, Roy M. Ueland, Per M. Nystad, Wenche London, Stephanie J. Motsinger-Reif, Alison Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero |
title | Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero |
title_full | Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero |
title_fullStr | Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero |
title_full_unstemmed | Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero |
title_short | Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero |
title_sort | maternal smoking impacts key biological pathways in newborns through epigenetic modification in utero |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124223/ https://www.ncbi.nlm.nih.gov/pubmed/27887572 http://dx.doi.org/10.1186/s12864-016-3310-1 |
work_keys_str_mv | AT rotroffdanielm maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT joubertbonnier maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT marvelskylarw maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT habergsirie maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT wumichaelc maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT nilsenroym maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT uelandperm maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT nystadwenche maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT londonstephaniej maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero AT motsingerreifalison maternalsmokingimpactskeybiologicalpathwaysinnewbornsthroughepigeneticmodificationinutero |